Point-of-Care Influenza Diagnostics Market Forecast Report 2025-2033: Opportunities in Rising Demand for Rapid Tests, Advancements in Test Sensitivity, a…

Key market opportunities in the point-of-care influenza diagnostics market include the rising demand for rapid tests due to ...
La Grande Observer

Aptitude Receives FDA Authorization for Metrix® COVID/Flu Multiplex Molecular Test for Point-of-Care and Over-the-Counter Use

SANTA BARBARA, Calif., Feb. 24, 2025 /PRNewswire/ — Aptitude Medical Systems, Inc. (Aptitude) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug ...
Morningstar

Alveo Technologies Successfully Fulfills Expanded CDC Milestone Agreement to Advance its Rapid Molecular Test for both Seasonal and Avian Influenza A(H5) in Humans

Using both nasal and conjunctival sample types, Alveo's point of care, cloud-connected molecular testing solution detects and differentiates between Influenzas A, B and A(H5) in humans ALAMEDA, Calif.